ARCHIMED is a global investment firm specializing in the healthcare sector, investing in small to midsize companies. With a focus on growth and business development, the firm operates across seven healthcare sub-sectors and is committed to sustainable investment, aligning with social health objectives.
- Healthcare
- Pharmaceuticals
- Biotechnology
- Clinical Research
- Dermatology
- Oncology
- Inflammatory Diseases
- Medical Devices
- Women's Health
- Internal Medicine
Leadership
Name | Title | ||
---|---|---|---|
Vincent Guillaumot | Managing Partner |
in/vincentguillaumot
|
|
Managing Partner |
|
|
|
Managing Partner |
|
|
|
Partner |
|
|
|
Partner |
|
|
|
Partner |
|
|
|
Partner |
|
|
|
Partner |
|
|
|
Partner |
|
|
|
Partner |
|
|
|
Partner |
|
|
|
Partner |
|
|
|
Partner |
|
|
|
Partner |
|
|
|
Partner |
|
|
|
Managing Director |
|
|
|
Managing Director |
|
|
|
Chairman, Managing Partner |
|
|
Recent Transactions involving ARCHIMED
Deal | Target | Platform | Buyer | Industry |
---|---|---|---|---|
ARCHIMED buys Cellese, a pioneering developer of growth factors and exosome-based skincare products |
Cellese |
ARCHIMED |
Dermo Cosmetics | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
||
|
|
|
|
|
|
|
|
||
|
|
|
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →